Wednesday, March 12, 2014 12:08:23 PM
"Although I can make no assurances, it is my belief that if our MIRROR® trial is able to show clear indications of heart muscle regeneration in those suffering from heart failure our valuation in market cap may increase significantly." Mike Tomas
http://stemcellceo.com/wp/bioheart/the-mirror-phase-iii-trial/
The posts contained on this account are my own opinions and are not recommendations or advise to buy or sell any security, stock other investments.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM